Products for Research Use Only
RegisterLogin

APNmAb005

CAT: 0804-HY-P991373-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991373-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
APNmAb005 is a human monoclonal antibody (mAb) targeting MAPT/Tau/PHF-tau. APNmAb005 blocks tau seeding in vitro and rescues neuronal loss in rTG4510 mice. APNmAb005 can be used in Alzheimer’s disease (AD) research[1].
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
Tau Protein
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Purity
97.64
Smiles
[APNmAb005]
Molecular Weight
(145.92 kDa)
Precautions
H302, H315, H319, H335
References & Citations
[1]Tai C Y, et al. APNmAb005, an anti‐tau antibody targeting synaptic tau oligomers, in Phase 1 for treatment of Alzheimer’s Disease and primary tauopathies[J]. Alzheimer's & Dementia, 2023, 19: e076888.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
T9901A-1019-01APNmAb005
PTX26260Anti-Human MAPT/Tau/PHF-tau (APNmAb005)
MBS1581019-01Research Grade Anti-Human MAPT/Tau/PHF-tau (APNmAb005)
A136670Anti-MAPT/Tau/PHF-tau (APNmAb005) Biosimilar (Monoclonal, IgG)

Popular Products